News Coverage 10.17.19 By: Mark Terry Share on Twitter Share on Facebook Share on LinkedIn ArsenalBio Launches with $28 Million Series A to Develop Next-Generation Immunotherapies Related Announcement, Press Release Alliance Aims to Develop Next-Gen Cancer Therapies Announcement, Press Release Biomarkers May Predict Better Treatment Options Announcement, Press Release First Patients Dosed in Pancreatic Platform Trial